Monocytes with Oncogenic Mutation JAK2 V617F as a Tool for Studies of the Pathogenic Mechanisms of Myelofibrosis

Bull Exp Biol Med. 2018 Mar;164(4):569-575. doi: 10.1007/s10517-018-4033-x. Epub 2018 Mar 5.

Abstract

We analyzed previously generated stable monocyte-derived cell line carrying mutation JAK2 V617F. Evaluation of the expression of pro- and antifibrotic factors revealed changes in the production of MMPs and their inhibitors, growth factors, galectin-3, and pentraxin 3 in cells carrying mutation JAK2 in comparison with control non-modified cells.

Keywords: JAK2 V617F; macrophages; myeloproliferative neoplasms; primary myelofibrosis.

MeSH terms

  • Blood Proteins
  • C-Reactive Protein / genetics
  • C-Reactive Protein / metabolism
  • Cell Communication
  • Coculture Techniques
  • Galectin 3 / genetics
  • Galectin 3 / metabolism
  • Galectins
  • Gene Expression Regulation*
  • Humans
  • Janus Kinase 2 / genetics*
  • Janus Kinase 2 / metabolism
  • Matrix Metalloproteinases / genetics
  • Matrix Metalloproteinases / metabolism
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / metabolism*
  • Models, Biological
  • Mutation*
  • Primary Cell Culture
  • Primary Myelofibrosis / genetics
  • Primary Myelofibrosis / metabolism
  • Primary Myelofibrosis / pathology
  • Protein Isoforms / genetics
  • Protein Isoforms / metabolism
  • Serum Amyloid P-Component / genetics
  • Serum Amyloid P-Component / metabolism
  • Signal Transduction
  • THP-1 Cells
  • Tissue Inhibitor of Metalloproteinases / genetics
  • Tissue Inhibitor of Metalloproteinases / metabolism

Substances

  • Blood Proteins
  • Galectin 3
  • Galectins
  • LGALS3 protein, human
  • Protein Isoforms
  • Serum Amyloid P-Component
  • Tissue Inhibitor of Metalloproteinases
  • PTX3 protein
  • C-Reactive Protein
  • JAK2 protein, human
  • Janus Kinase 2
  • Matrix Metalloproteinases